IN BRIEF: Oxford BioDynamics director sells over 700,000 shares
Oxford BioDynamics PLC - biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform - Reports that Vulpes Testudo Fund, controlled by...
Fri, 20/10/2023 - 10:32